Breakthrough heart procedure tested in first human patients
NCT ID NCT06452589
Summary
This first-in-human study is testing a new medical device called the FieldForce Ablation System for treating atrial fibrillation, a common heart rhythm disorder. The trial will enroll 40 patients to see if this new pulsed field ablation technology is safe and can effectively isolate problematic heart tissue. Unlike traditional heat-based methods, this approach uses electrical pulses to target cells while potentially reducing damage to surrounding areas.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL ARRHYTHMIAS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Na Homolce Hospital
RECRUITINGPrague, 150 00, Czechia
Contact
Contact
Conditions
Explore the condition pages connected to this study.